Sutton Place Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$613K Buy
666
+106
+19% +$107K 0.34% 68
2025
Q4
$602K Buy
560
+77
+16% +$73.6K 0.33% 65
2025
Q3
$369K Sell
483
-24
-5% -$17.9K 0.21% 93
2025
Q2
$395K Sell
507
-8
-2% -$6.22K 0.24% 80
2025
Q1
$425K Sell
515
-1,738
-77% -$1.45M 0.29% 71
2024
Q4
$1.74M Sell
2,253
-20
-0.9% -$16.6K 1.01% 33
2024
Q3
$2.01M Buy
2,273
+60
+3% +$53.9K 1.23% 21
2024
Q2
$2M Sell
2,213
-1,987
-47% -$1.59M 1.33% 20
2024
Q1
$3.27M Buy
4,200
+1,995
+90% +$1.42M 1.62% 15
2023
Q4
$1.29M Buy
+2,205
New +$1.29M 0.93% 31

Other funds holding LLY

Sutton Place Investors's LLY Position: Q1 2026 in Review

Sutton Place Investors increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $107K and bringing the position to 666 shares worth $613K. The position accounts for 0.34% of the portfolio, ranked #68.

Sutton Place Investors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.27M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sutton Place Investors held 666 shares of Eli Lilly worth $613K as of Q1 2026.
  • Sutton Place Investors bought 106 Eli Lilly shares in Q1 2026, an estimated $107K.
  • Eli Lilly made up 0.34% of Sutton Place Investors's portfolio in Q1 2026, its #68 holding.
  • Sutton Place Investors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Sutton Place Investors's Eli Lilly position peaked at $3.27M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sutton Place Investors's 13F filing for Q1 2026, filed 22 Apr 2026.